VincentTrien-VinhHoMD

Hematologic Oncology

Clinical Director, Allogeneic Hematopoietic Stem Cell Transplantation, Dana-Farber Cancer Institute. Associate Professor of Medicine, Harvard Medical School

Join to view full profile

Dr. Ho is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Ho's full profile

Already have an account?

Office
Dana-Farber Cancer Institute
450 Brookline Ave
Boston, MA 02115
Phone+1 617-632-5938

Fax+1 617-632-5168
Is this information wrong?

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1999 - 2002
Brigham and Women's HospitalResidency, Internal Medicine, 1997 - 1999
Brigham and Women's HospitalInternship, Internal Medicine, 1996 - 1997
Harvard Medical SchoolClass of 1996

Certifications & Licensure

MA State Medical License 2000 - 2025
NH State Medical License 2023 - 2025
RI State Medical License 2022 - 2024

Clinical Trials

Treatment for Acute Graft-Versus-Host Disease (BMT CTN 0302) Start of enrollment: 2005 Sep 01
Completed
Phase 2
Tacrolimus and Sirolimus as Prophylaxis After Allogenic Non-myeloablative Peripheral Blood Stem Cell Transplantation Start of enrollment: 2006 Jan 01
Completed
Phase 2
CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation Start of enrollment: 2005 Sep 01
Completed
Not Applicable
Effectiveness of Etanercept for Idiopathic Pneumonia Syndrome Following Stem Cell Transplantation (BMT CTN 0403) Start of enrollment: 2007 Aug 01
Completed
Phase 3
GM-CSF Vaccinations After Allogeneic Blood Stem Cell Transplantation in Patients With Advanced Myeloid Malignancies Start of enrollment: 2004 Jun 01
Completed
Not Applicable
Vaccination With GM-K562 Cells in Patients With Advanced Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) After Allogeneic Hematopoetic Stem Cell Transplantation Start of enrollment: 2008 Nov 01
Completed
Phase 1
Collection and Banking of Leukemia Cells MDS/AML Start of enrollment: 2008 Oct 01
Completed
Not Applicable
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802) Start of enrollment: 2010 Jan 01
Completed
Phase 3
Ex Vivo TCR αβ T Cell Depletion for Graft-Versus-Host Disease Prophylaxis in Mismatched Donor Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies Start of enrollment: 2020 Jan 21
Terminated
Phase 2
Join now to see all

Publications & Presentations

PubMed

1 citations
Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML.
Garcia, J., Kim, H., Murdock, H., Ansuinelli, M., Brock, J., Cutler, C., Gooptu, M., Ho, V., Koreth, J., Nikiforow, S., Romee, R., Shapiro, R., DeAngelo, D., Stone, R....> ;Blood Advances. 2024 Feb 27
Heightened TLR7 signaling primes BCR-activated B cells in chronic graft-versus-host disease for effector functions.
Bracken, S., Suthers, A., DiCioccio, R., Su, H., Anand, S., Poe, J., Jia, W., Visentin, J., Basher, F., Jordan, C., McManigle, W., Li, Z., Hakim, F., Pavletic, S., Bhu...> ;Blood Advances. 2024 Feb 13
Innovations in conditioning and post-transplant maintenance in AML: genomically informed revelations on the graft-versus-leukemia effect.
H Moses Murdock, Vincent T Ho, Jacqueline S Garcia> ;Frontiers in Immunology. 2024 Jan 1
1 citations
Opportunistic Infections in Patients Receiving Post-Transplantation Cyclophosphamide: Impact of Haploidentical versus Unrelated Donor Allograft.
Jessica S Little, Rémy Duléry, Roman M Shapiro, Muneerah M Aleissa, Susan E Prockop, John Koreth, Jerome Ritz, Joseph H Antin, Corey Cutler, Sarah Nikiforow, Rizwan Ro...> ;Transplantation and Cellular Therapy. 2024 Feb 1
5 citations
Posttransplant cyclophosphamide vs tacrolimus-based GVHD prophylaxis: lower incidence of relapse and chronic GVHD.
Katie Maurer, Vincent T Ho, Eno Inyang, Corey Cutler, John Koreth, Roman M Shapiro, Mahasweta Gooptu, Rizwan Romee, Sarah Nikiforow, Joseph H Antin, Catherine J Wu, Je...> ;Blood Advances. 2023 Aug 8
Cell Therapy Informatics: Updates on the Integration of HCT/IEC Functionalities into an Electronic Medical Record System in the US to Promote Efficiency, Patient Safet...
Vincent T Ho, Thomas R Klumpp, Wayne H Liang, Matt Prestegaard, Mitchell Horwitz, Betty K Hamilton, Kristin Page, Samantha Jaglowski, John Huber, Charles Martinez, Vin...> ;Transplantation and Cellular Therapy. 2023 Sep 1
Cytokine release syndrome in haploidentical stem cell transplant may impact T-cell recovery and relapse.
Roman M Shapiro, Haesook T Kim, Michela Ansuinelli, Indira Guleria, Corey S Cutler, John Koreth, Mahasweta Gooptu, Joseph H Antin, Amar Kelkar, Jerome Ritz, Catherine ...> ;Blood Advances. 2023 Aug 8
4 citations
Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for IDH1-Mutated Acute Myeloid Leukemia.
Amir T Fathi, Haesook T Kim, Robert J Soiffer, Mark J Levis, Shuli Li, Annette S Kim, Zachariah DeFilipp, Areej El-Jawahri, Steve L McAfee, Andrew M Brunner, Philip C ...> ;Clinical Cancer Research. 2023 Jun 1
Clinical Features of Acute Kidney Injury in the Early Post-Transplantation Period Following Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplan...
Juliana Vergara-Cadavid, P Connor Johnson, Haesook T Kim, Alisha Yi, Meghan E Sise, David E Leaf, Paul E Hanna, Vincent T Ho, Corey S Cutler, Joseph H Antin, Mahasweta...> ;Transplantation and Cellular Therapy. 2023 Jul 1
2 citations
Phase 2 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease.
Anita G Koshy, Haesook T Kim, Jessica Liegel, Jon Arnason, Vincent T Ho, Joseph H Antin, Robin Joyce, Corey Cutler, Mahasweta Gooptu, Sarah Nikiforow, Emma K Logan, Pa...> ;Blood. 2023 Jun 15
3 citations
Lower incidence of chronic GVHD observed after transplantation with cryopreserved unrelated allogeneic stem cells.
Katie Maurer, Haesook T Kim, Heather M Garrity, Deborah Liney, Corey Cutler, Joseph H Antin, John Koreth, Jerome Ritz, Roman M Shapiro, Rizwan Romee, Vincent T Ho, Mah...> ;Blood Advances. 2023 Jun 13
Intensity of induction regimen and outcomes among adults with Ph+ALL undergoing allogeneic hematopoietic stem cell transplantation.
Hari S Raman, Se Eun Kim, Daniel J DeAngelo, Kristen E Stevenson, Donna Neuberg, Eric S Winer, Martha Wadleigh, Jacqueline S Garcia, Annette S Kim, Richard M Stone, Vi...> ;Leukemia Research. 2023 Feb 1
1 citations
Prognostic Biomarkers for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Myeloablative Allogeneic Hematopoietic Cell Transplantation: Results from t...
Santosh Putta, Bradford A Young, John E Levine, Ran Reshef, Ryotaro Nakamura, Christopher Strouse, Miguel-Angel Perales, Alan Howard, Polly Pine, Ju Shi, Peixin Zhang,...> ;Transplantation and Cellular Therapy. 2023 Mar 1
20 citations
Enasidenib as maintenance following allogeneic hematopoietic cell transplantation for IDH2-mutated myeloid malignancies.
Fathi, A., Kim, H., Soiffer, R., Levis, M., Li, S., Kim, A., Mims, A., DeFilipp, Z., El-Jawahri, A., McAfee, S., Brunner, A., Narayan, R., Knight, L., Kelley, D., Bott...> ;Blood Advances. 2022 Nov 22
17 citations
Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings.
Jacqueline S Garcia, Yael Flamand, Livius Penter, Michael Keng, Benjamin K Tomlinson, Lourdes M Mendez, Paul Koller, Nicole Cullen, Yohei Arihara, Kathleen Pfaff, Jacq...> ;Blood. 2023 Apr 13
2 citations
Hepatitis B Virus Vaccination after Allogeneic Hematopoietic Cell Transplantation Prevents Post-Transplantation Hepatitis B Virus Reactivation.
Sarah P Hammond, Vincent T Ho, Francisco M Marty> ;Transplantation and Cellular Therapy. 2022 Jul 1
25 citations
Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML.
H Moses Murdock, Haesook T Kim, Nathan Denlinger, Pankit Vachhani, Bryan Hambley, Bryan S Manning, Shannon Gier, Christina Cho, Harrison K Tsai, Shannon McCurdy, Vince...> ;Blood. 2022 Jun 16
7 citations
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine.
Park, J., Mathieu Gigoux, Morten O Holmström, Roberta Zappasodi, Joseph J Park, Stephane Pourpe, Cansu Cimen Bozkus, Levi M B Mangarin, David Redmond, Svena Verma, Sar...> ;Science Translational Medicine. 2022 Jun 15
1 citations
Outcomes of allogeneic haematopoietic cell transplantation for chronic neutrophilic leukaemia: A combined CIBMTR/CMWP of EBMT analysis.
Bhagirathbhai Dholaria, Aleksandar Radujkovic, Noel Estrada-Merly, Tiarlan Sirait, Soyoung Kim, Juan Carlos Hernández-Boluda, Tomasz Czerw, Patrick J Hayden, Ankit Kan...> ;British Journal of Haematology. 2022 Aug 1
44 citations
Expansion, persistence, and efficacy of donor memory-like NK cells infused for posttransplant relapse.
Roman M Shapiro, Grace C Birch, Guangan Hu, Juliana Vergara Cadavid, Sarah Nikiforow, Joanna Baginska, Alaa K Ali, Mubin Tarannum, Michal Sheffer, Yasmin Z Abdulhamid,...> ;The Journal of Clinical Investigation. 2022 Jun 1
8 citations
Organ-specific response after low-dose interleukin-2 therapy for steroid-refractory chronic graft-versus-host disease.
Haesook T Kim, John Koreth, Jennifer Whangbo, Sarah Nikiforow, Carol G Reynolds, Peter Stowe, Vincent T Ho, Corey Cutler, Joseph H Antin, Robert J Soiffer, Jerome Ritz> ;Blood Advances. 2022 Aug 9
8 citations
Invasive Yeast Infection after Haploidentical Donor Hematopoietic Cell Transplantation Associated with Cytokine Release Syndrome.
Jessica S Little, Roman M Shapiro, Muneerah M Aleissa, Austin Kim, Jun Bai Park Chang, David W Kubiak, Guohai Zhou, Joseph H Antin, John Koreth, Sarah Nikiforow, Corey...> ;Transplantation and Cellular Therapy. 2022 Aug 1
2 citations
Phenotypic and functional characterization of the CD6-ALCAM T-cell co-stimulatory pathway after allogeneic cell transplantation.
Benedetta Rambaldi, Haesook T Kim, Yohei Arihara, Takeru Asano, Carol Reynolds, Mariah Manter, Max Halpern, Augustine Weber, John Koreth, Corey Cutler, Mahasweta Goopt...> ;Haematologica. 2022 Nov 1
11 citations
A phase 1 study of donor regulatory T-cell infusion plus low-dose interleukin-2 for steroid-refractory chronic graft-vs-host disease.
Jennifer S Whangbo, Sarah Nikiforow, Haesook T Kim, Jonathan Wahl, Carol G Reynolds, Sharmila C Rai, Soomin Kim, Andrew Burden, Ana C Alho, João F Lacerda, Edwin P Aly...> ;Blood Advances. 2022 Nov 8
6 citations
Favorable outcomes following allogeneic transplantation in adults with hemophagocytic lymphohistiocytosis.
Mahasweta Gooptu, Haesook T Kim, Eric Jacobsen, David C Fisher, Ann LaCasce, Vincent T Ho, Corey S Cutler, John Koreth, Robert J Soiffer, Joseph H Antin, Nancy Berline...> ;Blood Advances. 2023 Jun 13
Join now to see all

Abstracts/Posters

Outcome of Autologous Stem Cell Transplantation Following PD-(L)1 Based Salvage Therapy for Multiply Relapsed Patients with Classic Hodgkin Lymphoma
Vincent T. Ho, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
A Phase 1 Dose-Escalation Study of Adding Venetoclax to a Reduced Intensity Conditioning (RIC) Regimen Prior to Allogeneic Hematopoietic Cell Transplantation for Patie...
Vincent T. Ho, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Improved Outcomes with Cyclophosphamide/Total Body Irradiation 14 Gy Compared to Cyclophosphamide/Total Body Irradiation 12 Gy in Patients with Acute Lymphoblastic Leu...
Vincent T. Ho, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Single-Cell RNA-Seq Identifies Potentially Pathogenic B Cell Populations That Uniquely Circulate in Patients with Chronic Gvhd
Vincent T. Ho, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Distinct Evolutionary Patterns in Chronic Lymphocytic Leukemia (CLL) during Resistance to Graft-Versus-Leukemia (GvL)
Vincent T. Ho, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Safety and Efficacy of Allogeneic Hematopoietic Stem Cell Transplant after Programmed Cell Death 1 (PD-1) / Programmed Cell Death Ligand 1 (PD-L1) Blockade for Classic...
Vincent T. Ho, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Graft Failure after Haploidentical Hematopoietic Stem Cell Transplantation
Vincent T. Ho, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Clinical and Immunologic Activity of Ipilimumab Following Decitabine Priming in Post-Allogeneic Transplant and Transplant-Na¥ve Patients with Relapsed or Refractory My...
Vincent T. Ho, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Anti-CD6 Monoclonal Antibody Itolizumab Efficiently Inhibits T Cell Proliferation after in Vitro TCR Stimulation in the Setting of Acute Graft Versus Host Disease
Vincent T. Ho, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Join now to see all

Lectures

Allogeneic Stem Cell Transplantation Provides Durable Remission in Patients with Primary Mediastinal Large B-Cell Lymphoma
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018